Loading…
ARS Pharmaceuticals, Inc. is projected to decline to $5.05 by 2027, a -1% move from its current price of $5.13. SPRY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $4.94 | $5.13 | $5.32 | -0.08% |
| Aug 3 | $4.87 | $5.12 | $5.39 | -0.15% |
| Aug 4 | $4.81 | $5.12 | $5.45 | -0.23% |
| Aug 5 | $4.76 | $5.11 | $5.50 | -0.30% |
| Aug 6 | $4.71 | $5.11 | $5.54 | -0.38% |
| Aug 7 | $4.67 | $5.11 | $5.58 | -0.45% |
| Aug 8 | $4.64 | $5.10 | $5.62 | -0.53% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.64 | $5.10 | $5.62 | -0.53% |
| Week 2 | $4.43 | $5.08 | $5.81 | -1.05% |
| Week 3 | $4.28 | $5.05 | $5.96 | -1.57% |
| Week 4 | $4.15 | $5.02 | $6.08 | -2.09% |
| Week 5 | $4.03 | $5.00 | $6.19 | -2.60% |
| Week 6 | $3.93 | $4.97 | $6.29 | -3.12% |
| Week 7 | $3.84 | $4.94 | $6.37 | -3.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis.
ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California. The company operates within the Healthcare sector.
ARS Pharmaceuticals, Inc. trades under the symbol SPRY. The current price is $5.13 and the market cap is $509.43M, with a rank of 2890.
The price outlook based on year-by-year forecasts shows a neutral to bullish trajectory over time. The 2026 forecast sets the average price at $5.13 and the 2027 forecast at $5.05, with a forward path that climbs to a higher long-run level by 2030 and beyond.
Forecasts progress from neutral in the near term to bullish in the longer term. The 2030–2050 horizon shows steadily rising averages, culminating in a $21.47 average by 2050, with substantial upside as captured by the ROI figures (e.g., 21 in 2030, 133.1 by 2040, and 318.5 by 2050).
A major floor 70.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.0% away) — a key level to hold.
The nearest ceiling, 105.5% above — a clean break opens room to run.
A major ceiling 140.6% above — clearing it would confirm fresh momentum.
Key SPRY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SPRY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.60 | Sell | $5.59 | Sell |
| MA 10 | $5.88 | Sell | $5.97 | Sell |
| MA 20 | $6.83 | Sell | $6.65 | Sell |
| MA 50 | $8.14 | Sell | $7.61 | Sell |
| MA 100 | $8.18 | Sell | $8.24 | Sell |
| MA 200 | $8.99 | Sell | $9.17 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 21.83 | Buy |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -119.49 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.12 | Sell |
| ROC (12) | -32.05 | Sell |
| Bollinger %B (20,2) | 0.08 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -1.29 | Sell |
| Awesome (5,34) | -2.22 | Sell |
| Ultimate (7,14,28) | 12.05 | Buy |
| Momentum (10) | -1.87 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 5.44 | Sell |
| ADX (14) | 35.15 | Sell |
| ATR (14) | 0.25 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 is 20, with the 50-day simple moving average at $8.14 and the 200-day simple moving average at $8.99.
Support is listed at $5.13 and resistance at $10.54. The 30-day price range spans from a low of $4.04 to a high of $6.51, reflecting a tight near-term band around the current price.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $5.13 | $5.13 | $6.01 | 0% | Neutral | |
| $3.91 | $5.05 | $6.97 | -1% | Neutral | |
| $3.93 | $5.28 | $7.63 | +3% | Neutral | |
| $3.55 | $4.93 | $7.40 | -4% | Neutral | |
| $4.35 | $6.21 | $9.61 | +21% | Bullish | |
| $5.09 | $7.47 | $11.87 | +46% | Bullish | |
| $5.13 | $7.71 | $12.55 | +50% | Bullish | |
| $5.07 | $7.80 | $12.98 | +52% | Bullish | |
| $4.74 | $7.46 | $12.64 | +45% | Bullish | |
| $4.87 | $7.83 | $13.51 | +53% | Bullish | |
| $6.73 | $11.96 | $22.25 | +133% | Bullish | |
| $10.11 | $21.47 | $44.49 | +319% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $5.13 | $5.13 | $6.05 | +0.00% |
| September 2026 | $3.98 | $4.75 | $5.87 | -7.35% |
| October 2026 | $3.97 | $4.79 | $6.00 | +0.76% |
| November 2026 | $3.99 | $4.84 | $6.14 | +1.15% |
| December 2026 | $3.84 | $4.70 | $6.01 | -3.01% |
Click any year to see its month-by-month SPRY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, SPRY could reach as high as $6.01, with a base case around $5.13 and support toward $5.13 — roughly 0% from $5.13. A consolidation phase looks the most probable path here.
Expect SPRY to range from $3.91 to $6.97 through 2027. The $5.05 average target implies a -1% move from current prices. That is -1% versus the projected 2026 average. Price action looks broadly range-bound.
The SPRY price prediction for 2028 points to an average of $5.28 (low $3.93, high $7.63) — a potential gain of +3% on today's $5.13. A consolidation phase looks the most probable path here.
In 2029, SPRY is projected to trade between $3.55 and $7.40, averaging $4.93 — a potential decline of -4% from today's $5.13. That is -7% versus the projected 2028 average. Price action looks broadly range-bound.
ARS Pharmaceuticals, Inc.'s 2030 outlook centres on $6.21, within a $4.35 to $9.61 range. That is up +26% on the projected 2029 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, SPRY could reach as high as $11.87, with a base case around $7.47 and support toward $5.09 — roughly +46% from $5.13. Momentum favours further upside here.
Expect SPRY to range from $5.13 to $12.55 through 2032. The $7.71 average target implies a +50% move from current prices. That is up +3% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The SPRY price prediction for 2033 points to an average of $7.80 (low $5.07, high $12.98) — a potential gain of +52% on today's $5.13. Momentum favours further upside here.
In 2034, SPRY is projected to trade between $4.74 and $12.64, averaging $7.46 — a potential gain of +45% from today's $5.13. That is -4% versus the projected 2033 average. Buyers look set to stay in control over this stretch.
ARS Pharmaceuticals, Inc.'s 2035 outlook centres on $7.83, within a $4.87 to $13.51 range. That is up +5% on the projected 2034 average. That marks a +53% change versus current levels. Momentum favours further upside here.
By 2040, SPRY could reach as high as $22.25, with a base case around $11.96 and support toward $6.73 — roughly +133% from $5.13. Buyers look set to stay in control over this stretch.
Expect SPRY to range from $10.11 to $44.49 through 2050. The $21.47 average target implies a +319% move from current prices. That is up +80% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SPRY today (≈ 194.931774 SPRY) could be worth
$4,184.98
+$3,184.98 (+318%) by 2050 · US Dollar
Based on the average projected SPRY price of $21.47 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SPRYwould be worth at today's price.
$1,000 invested in SPRY on Jul 31, 2025 (≈ 56.561085 SPRY) would be worth
$290.16
-$709.84 (-71.0%) today · 0.29× · US Dollar
Based on a SPRY entry price of $17.68 vs. today's $5.13.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.94 | $863.64 | -13.6% |
| 1 month ago | $7.94 | $646.1 | -35.4% |
| 3 months ago | $8.56 | $599.3 | -40.1% |
| 6 months ago | $10.3 | $498.06 | -50.2% |
| 1 year ago | $17.68 | $290.16 | -71.0% |
| All time (5.0y) ago | $29.98 | $171.11 | -82.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SPRY forecast.
Our base-case forecast reaches $10.00 around 2040.
Implied market cap at $10.00: $993.03M
The multi-year forecast shows a bullish shift beginning in 2030, with an average price of $6.21, a minimum of $4.35, and a maximum of $9.61; the forecasted ROI is 21 and sentiment is BULLISH.
From 2031 through 2035, the average prices rise (2031 $7.47, 2032 $7.71, 2033 $7.80, 2034 $7.46, 2035 $7.83) with ROIs of 45.6, 50.3, 52.1, 45.4, and 52.6 respectively, all bearing a BULLISH sentiment. The long-run volatility remains high (annualized volatility 70).
Looking further out, the 2040 forecast shows an average of $11.96 with a min of $6.73 and a max of $22.25, ROI 133.1, framed as BULLISH. By 2050, the average rises to $21.47 (min $10.11, max $44.49) with ROI 318.5, also labeled BULLISH. This path reflects meaningful upside potential over the long horizon, alongside substantial risk given the volatility level.
Tap a question to reveal the answer.
2030 forecast: min $4.35, avg $6.21, max $9.61; ROI 21; sentiment BULLISH.
The forecast shows BULLISH sentiment from 2030 onward with higher avg prices by 2040 ($11.96) and 2050 ($21.47); ROIs of 133.1 and 318.5 respectively. Early years show neutral to negative returns and high volatility (annualized volatility 70).
Yes. The max forecast reaches $11.87 in 2031, $12.55 in 2032, $12.98 in 2033, and $13.51 in 2035, with a long-run peak of $22.25 by 2040.
Current price $5.13; market cap $509.43M.
30-day range: low $4.04, high $6.51.
ARS Pharmaceuticals, Inc. Community Discussion
0Share your ARS Pharmaceuticals, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.